Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
Newron Pharmaceuticals SpA (NWPHF) Stock Price & Analysis
9 Followers
NWPHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.10 - $12.00
Previous Close$12
Volume100.00
Average Volume (3M)621.00
Market Cap
$174.48M
Enterprise Value$199.41M
Total Cash (Recent Filing)€22.77M
Total Debt (Recent Filing)€45.66M
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Sep 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding17,845,345
10 Day Avg. Volume0
30 Day Avg. Volume621
Standard Deviation0.19
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
<0.01% Mutual Funds
0.34% Other Institutional Investors
99.66% Public Companies and
Individual Investors
NWPHF FAQ
What was Newron Pharmaceuticals SpA’s price range in the past 12 months?
Newron Pharmaceuticals SpA lowest stock price was $2.10 and its highest was $12.00 in the past 12 months.
What is Newron Pharmaceuticals SpA’s market cap?
Currently, no data Available
When is Newron Pharmaceuticals SpA’s upcoming earnings report date?
Newron Pharmaceuticals SpA’s upcoming earnings report date is Sep 19, 2024 which is in 55 days.
How were Newron Pharmaceuticals SpA’s earnings last quarter?
Newron Pharmaceuticals SpA released its earnings results on Mar 19, 2024. The company reported -$0.56 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.56.
Is Newron Pharmaceuticals SpA overvalued?
According to Wall Street analysts Newron Pharmaceuticals SpA’s price is currently Overvalued.
Does Newron Pharmaceuticals SpA pay dividends?
Newron Pharmaceuticals SpA does not currently pay dividends.
What is Newron Pharmaceuticals SpA’s EPS estimate?
Newron Pharmaceuticals SpA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Newron Pharmaceuticals SpA have?
Newron Pharmaceuticals SpA has 19,047,516 shares outstanding.
What happened to Newron Pharmaceuticals SpA’s price movement after its last earnings report?
Newron Pharmaceuticals SpA reported an EPS of -$0.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Newron Pharmaceuticals SpA?
Currently, no hedge funds are holding shares in NWPHF
---
Newron Pharmaceuticals SpA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
471.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-28.02%
Trailing 12-Months
Company Description
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
---
NWPHF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ACADIA Pharmaceuticals
―
Alnylam Pharma
―
Arrowhead Pharmaceuticals
―
BioMarin Pharmaceutical
―
Best Analysts Covering NWPHF
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+40.80%
reiterated a buy rating 6 months ago
Copying Leonildo Delgado's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.80% per trade.
---